Resultados da pesquisa - Portal para modelos de dados médicos (portal MDM)

Filtrar os resultados da pesquisa
Selecionar modelos de dados

Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

4 Resultados da pesquisa.

Riliva_CRF_EudraCT - Nr. 2012-000108-13- Screening DRKS00004652 - Screening II

- 17/09/2021 - 2 Formulários, 4 Grupos de itens, 41 Elementos de dados, 2 Idiomas

Grupos de itens: Basic data, Inclusion Criteria, Exclusion Criteria, Urine pregnancy test

Study documentation part: Screening. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Görge, University Hospital of Münster. EudraCT - Nr. 2012-000108-13.

Screening I

4 Grupos de itens 44 Elementos de dados

Examination_Riliva_CRF_EudraCT - Nr. 2012-000108-13 DRKS00004652 - Examination_Riliva_CRF_EudraCT - Nr. 2012-000108-13

- 15/03/2021 - 1 Formulário, 5 Grupos de itens, 59 Elementos de dados, 2 Idiomas

Grupos de itens: Vital Signs, skin examination, skin examination, LV - Score, skin examination Livedo racemosa

Study documentation part: Examination Week- 4, 8 and 12. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Grge, University Hospital of Mnster. EudraCT - Nr. 2012-000108-13.

Baseline Inspection_Riliva_CRF_EudraCT - Nr. 2012-000108-13 DRKS00004652 - Baseline Inspection_Riliva_CRF_EudraCT - Nr. 2012-000108-13

- 15/03/2021 - 1 Formulário, 5 Grupos de itens, 58 Elementos de dados, 2 Idiomas

Grupos de itens: Vital Signs, skin examination, skin examination, LV - Score, skin examination Livedo racemosa

Study documentation part: Baseline Inspection. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Görge, University Hospital of Münster. EudraCT - Nr. 2012-000108-13.

Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination DRKS00004652 - Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination

- 11/11/2015 - 1 Formulário, 1 Grupo de itens, 4 Elementos de dados, 2 Idiomas

Grupo de itens: Study termination

Study description: Study documentation part- Study termination. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Grge, University Hospital of Mnster. EudraCT - Nr. 2012-000108-13.

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.